QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
11.39
+0.15 (1.33%)
Apr 24, 2026, 10:19 AM EDT - Market open
QuidelOrtho Employees
QuidelOrtho had 6,500 employees as of December 28, 2025. The number of employees decreased by 100 or -1.52% compared to the previous year.
Employees
6,500
Change (1Y)
-100
Growth (1Y)
-1.52%
Revenue / Employee
$420,031
Profits / Employee
-$174,123
Market Cap
775.45M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 28, 2025 | 6,500 | -100 | -1.52% |
| Dec 29, 2024 | 6,600 | -500 | -7.04% |
| Dec 31, 2023 | 7,100 | 100 | 1.43% |
| Jan 1, 2023 | 7,000 | 5,400 | 337.50% |
| Jan 2, 2022 | 1,600 | 230 | 16.79% |
| Jan 3, 2021 | 1,370 | 120 | 9.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integra LifeSciences Holdings | 4,427 |
| Avanos Medical | 2,287 |
| Bioventus | 930 |
| Cytek Biosciences | 702 |
| InMode | 660 |
| SS Innovations International | 483 |
| SI-BONE | 376 |
| CeriBell | 327 |
QDEL News
- 1 day ago - Understanding and Addressing Syphilis Trends - and What's Being Missed - PRNewsWire
- 4 days ago - TTP Group Announces the Sale of LEX Diagnostics - Business Wire
- 4 days ago - QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics - PRNewsWire
- 7 days ago - QuidelOrtho Stock Sinks To 52-Week Low - Here's Why - Benzinga
- 8 days ago - QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance - PRNewsWire
- 4 weeks ago - Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer - PRNewsWire
- 2 months ago - Faster Cardiac Answers with High‑Sensitivity Troponin - PRNewsWire
- 2 months ago - QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - PRNewsWire